BioFlyte Successfully Validates Aerosolized Fentanyl Detection Capabilities
Following in-house and third-party validation testing, BioFlyte adds aerosolized fentanyl to its classification library and becomes only market solution proven to simultaneously sample for both chemical and biological threat agents
6K Additive Awarded Five-Year Blanket Purchase Agreement With the US Army Development Command
New BPA helps the US Army ensure national security while allowing weapons development from domestic feedstock of critical materials from 6K Additive’s UniMelt® production process
NUBURU Strengthens Executive Management Team
Fund III cohort accelerates the energy transition, facilitates discovery of better therapeutics and advances critical industries.
Anzu Partners Closes Third Venture Fund Focused on Companies Enabling Next-Gen Solutions in Clean Tech, Industrial, and Life Sciences Technologies
Fund III cohort accelerates the energy transition, facilitates discovery of better therapeutics and advances critical industries.
Aspinity Raises $5 Million Series B Funding to Bring Breakthrough AI/ML Technology to a Global Market
Strategic partnership with Unitrontech accelerates time to market for AI-based automotive impact and other AIoT solutions
Anzu Partners Elects Cathryn Paine to Partner
Anzu Partners Elects Cathryn Paine to Partner
BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization
As a part of the NIST Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products.
Niron Magnetics Expands its Focus on Government Relations with New Vice President of Government Affairs and New Board Member
Mark Schramek and Don Rosenberg bring extensive experience in government affairs and global policy to support Niron Magnetics’ corporate outreach and commercialization
NTx Awarded BARDA DRIVe Vaccines on Demand Contract to Demonstrate a Novel RNA Vaccine Production Platform
NTx will collaborate with Houston Methodist Hospital to demonstrate how NTxscribe® can fulfill the need for a rapidly deployable RNA vaccine manufacturing capability
Arduino Announces $22M in Additional Funding to Support Enterprise and Cloud Expansion
The global leader in empowering makers and students with accessible technology capitalizes on its ability to attract enterprise customers with its radically innovative industrial-grade PRO line.
New investments bring the total Series B funding amount to $54 million.
CDP Venture Capital, Italy’s largest VC firm, and previous investor Anzu Partners co-led, with Arm following up on their earlier investments.